Journal for ImmunoTherapy of Cancer (Nov 2020)
712 SBT6290, a systemically administered Nectin-4-directed TLR8 ImmunoTAC (TM) therapeutic, is a potent human myeloid cell agonist for the treatment of Nectin-4-expressing tumors
- Li-Qun Fan,
- Yvette Latchman,
- Jenny Chang,
- Valerie Odegard,
- Heather Metz,
- Ty Brender,
- Brenda Stevens,
- Damion Winship,
- Jamie Brevik,
- Michael Comeau,
- Monica Childs,
- Hengyu Xu,
- Jonathan Grey,
- Jeffrey Adamo,
- Ben Setter,
- Ray Carrillo,
- Sean Smith,
- Phil Tan,
- Robert DuBose,
- Peter Baum
Affiliations
- Li-Qun Fan
- Aff1 Research DepartmentDendreon Corporation Seattle WA USA
- Yvette Latchman
- Aff1 grid.421196.9Etubics Corporation Seattle WA USA
- Jenny Chang
- Medicine, University of California Irvine College of Medicine, Irvine, California, USA
- Valerie Odegard
- 5Silverback Therapeutics, Inc., Seattle, WA, USA
- Heather Metz
- Silverback Therapeutics, Seattle, WA, USA
- Ty Brender
- Silverback Therapeutics, Seattle, WA, USA
- Brenda Stevens
- Silverback Therapeutics, Seattle, WA, USA
- Damion Winship
- Silverback Therapeutics, Seattle, WA, USA
- Jamie Brevik
- Silverback Therapeutics, Seattle, WA, USA
- Michael Comeau
- Silverback Therapeutics, Seattle, WA, USA
- Monica Childs
- Silverback Therapeutics, Seattle, WA, USA
- Hengyu Xu
- Silverback Therapeutics, Seattle, WA, USA
- Jonathan Grey
- Silverback Therapeutics, Seattle, WA, USA
- Jeffrey Adamo
- Silverback Therapeutics, Seattle, WA, USA
- Ben Setter
- Silverback Therapeutics, Seattle, WA, USA
- Ray Carrillo
- Silverback Therapeutics, Seattle, WA, USA
- Sean Smith
- Silverback Therapeutics, Seattle, WA, USA
- Phil Tan
- Silverback Therapeutics, Seattle, WA, USA
- Robert DuBose
- Silverback Therapeutics, Seattle, WA, USA
- Peter Baum
- Silverback Therapeutics, Seattle, WA, USA
- DOI
- https://doi.org/10.1136/jitc-2020-SITC2020.0712
- Journal volume & issue
-
Vol. 8,
no. Suppl 3
Abstract
No abstracts available.
